Adjuvant Nutrition Management of Patients with Liver Failure, Including Transplant

Surgical Clinics of North America

Volumn 91, Issue 3, 2011, Pages 565-578

  Kerwin, Andrew J ^a,b   Nussbaum, Michael S ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH JACKSONVILLE   (United States)

Author keywords

Liver failure; Liver transplant; Malnutrition; Nutrition support

Indexed keywords

AMINO ACID; GLUCOSE; LIPID; PLASMA PROTEIN; PROTEIN;

ACUTE LIVER FAILURE; ALCOHOL LIVER DISEASE; BLOOD CLOTTING DISORDER; CALORIC INTAKE; DIET THERAPY; DISEASE ASSOCIATION; ENERGY METABOLISM; ENTERIC FEEDING; FIBRINOLYSIS; HEPATIC ENCEPHALOPATHY; HUMAN; JAUNDICE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER SURGERY; LIVER TRANSPLANTATION; MORTALITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN MALNUTRITION; PROTEIN SYNTHESIS; RETICULOENDOTHELIAL SYSTEM; REVIEW; VITAMIN DEFICIENCY;

ENERGY INTAKE; ENTERAL NUTRITION; HEPATITIS, ALCOHOLIC; HUMANS; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALNUTRITION; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PROTEIN-ENERGY MALNUTRITION;

EID: 79957547957     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2011.02.010     Document Type: Review

References (61)

1. Dudrick S.J., Kavic S.M. Hepatobiliary nutrition: history and future. J Hepatobiliary Pancreat Surg 2002, 9(4):459-468.
2. O'Grady J.G., Schlam S.W., Williams R. Acute liver failure: redefining the syndromes. Lancet 1993, 342:273-275.
3. Bernal W., Auzinger G., Dhawan A., et al. Acute liver failure. Lancet 2010, 376:190-201.
4. Cabre E., Gassull M.A. Nutrition in liver disease. Curr Opin Clin Nutr Metab Care 2005, 8(5):545-551.
5. O'Brien A., Williams R. Nutrition in end-stage liver disease: principles and practice. Gastroenterology 2008, 134(6):1729-1740.
6. Campillo B., Richardet J.P., Bories P.N. Validation of body mass index for the diagnosis of malnutrition in patients with liver cirrhosis. Gastroenterol Clin Biol 2006, 30:1137-1143.
7. Italian Multicentre Cooperative Project on nutrition in liver cirrhosis. Nutritional status in cirrhosis. J Hepatol 1994, 21:317-325.
8. Madden A.M., Bradbury W., Morgam M.Y. Taste perception in cirrhosis: its relationship to circulating, micronutrients and food preferences. Hepatology 1997, 26:40-48.
9. Thuluvath P.J., Triger D.R. Autonomic neuropathy and chronic liver disease. Q J Med 1989, 72(268):737-747.
10. Chaudhry V., Corse A.M., O'Brian R., et al. Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study. Hepatology 1999, 29(6):1698-1703.
11. Fleckenstein J.F., Frank S.M., Thuluvath P.J. Presence of autonomic neuropathy is a poor prognostic indicator in patients with advanced liver disease. Hepatology 1996, 23(3):471-475.
12. Schoonjans R., Van Vlem B., Vandamme W., et al. Gastric emptying of solids in cirrhotic and peritoneal dialysis patients: influence of peritoneal volume load. Eur J Gastroenterol Hepatol 2002, 14(4):395-398.
13. Chesta J., Defilippi C., Defilippi C. Abnormalities in proximal small bowel motility in patients with cirrhosis. Hepatology 1993, 17(5):828-832.
14. Galati J.S., Holdeman K.P., Bottjen P.L., et al. Gastric emptying and orocecal transit in portal hypertension and end-stage chronic liver disease. Liver Transpl Surg 1997, 3(1):34-38.
15. Maheshwari A., Thuluvath P.J. Autonomic neuropathy may be associated with delayed orocaecal transit time in patients with cirrhosis. Auton Neurosci 2005, 118:135-139.
16. Nagasako C.K., de Oliveira Figuerido M.J., de Souza Almeida J.R., et al. Investigation of autonomic function and orocecal transit time in patients with nonalcoholic cirrhosis and the potential influence of these factors on disease outcome. J Clin Gastroenterol 2009, 43:884-889.
17. Quigley E.M. Gastrointestinal dysfunction in liver disease and portal hypertension. Dig Dis Sci 1996, 41:557-561.
18. Aqel B.A., Scolapio J.S., Dickson R.C., et al. Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites. Clin Gastroenterol Hepatol 2005, 3(11):1095-1100.
19. Kondrup J., Muller M.J. Energy and protein requirements of patients with chronic liver disease. J Hepatol 1997, 27(1):239-247.
20. Galati J.S., Holdeman K.P., Dalrymple G.V., et al. Delayed gastric emptying of both the liquid and solid components of a meal in chronic liver disease. Am J Gastroenterol 1994, 89(5):708-711.
21. Isobe H., Sakai H., Satoh M., et al. Delayed gastric emptying in patients with liver cirrhosis. Dig Dis Sci 1994, 39(5):983-987.
22. Muller M.J., Lautz H.U., Plogmann B., et al. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992, 15(5):782-794.
23. Petrides A.S., DeFronzo R.A. Glucose metabolism in cirrhosis: a review with some perspective for the future. Diabetes Metab Rev 1989, 5(8):691-709.
24. Swart G.R., van den Berg J.W., van Vuure J.K., et al. Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake. Clin Nutr 1989, 8(6):329-336.
25. Swart G.R., Van den Berg J.W.O., Wattimena J.L., et al. Elevated protein requirements in cirrhosis of the liver investigated by whole body protein turnover studies. Clin Sci (Lond) 1988, 75(1):101-107.
26. Hiyama D.T., Fischer J.E. Nutritional support in hepatic failure: the current role of disease-specific therapy. Total Parenteral Nutrition 1991, 263-278. Little, Brown and Company, Boston/Toronto/London. 2nd Edition. J.E. Fischer (Ed.).
27. Marchesini G., Bugianesi E., Ronchi M., et al. Zinc supplementation improves glucose disposal in patients with cirrhosis. Metabolism 1998, 47:792-798.
28. Van der Rijt C.C., Schlam S.W., Schat H., et al. Overt hepatic encephalopathy precipitated by zinc deficiency. Gastroenterology 1991, 100(4):1114-1118.
29. Mendenhall C.L., Tosch T., Weesner R.E., et al. VA cooperative study on alcoholic hepatitis II: prognostic significance of protein-calorie malnutrition. Am J Clin Nutr 1986, 43:213-218.
30. Mendenhall C.L., Moritz T.E., Roselle G.A., et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs Cooperative Study. Hepatology 1993, 17:564-576.
31. Merli M., Romiti A., Riggio O., et al. Optimal nutritional indexes in chronic liver disease. JPEN J Parenter Enteral Nutr 1987, 11(Suppl 5):130S-134S.
32. Detsky A.S., McLaughlin J.R., Baker J.P., et al. What is subjective global assessment of nutritional status?. JPEN J Parenter Enteral Nutr 1987, 11(1):8-13.
33. Duerksen D.R. Teaching medical students the subjective global assessment. Nutrition 2002, 18(4):313-315.
34. Schutz T., Bechstein W.O., Neuhaus P., et al. Clinical practice of nutrition in acute liver failure-a European survey. Clin Nutr 2004, 23(5):975-982.
35. Martindale R.G., McClave S.A., Vanek V.W., et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. Crit Care Med 2009, 37(5):1-30.
36. Plauth M., Cabre E., Riggio O., et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 2006, 25:285-294.
37. Hahn M., Massen O., Nencki M., et al. Eck's fistula between the inferior vena cava and the portal vein: its consequences for the organism. Naunyn Schmiedebergs Arch Pharmacol 1893, 32:161-210.
38. Nencki M., Pawlow I. On the content of ammonia in blood within organs and on formation of urea in mammals. Naunyn Schmiedebergs Arch Pharmacol 1896, 37:26-51.
39. Nencki M., Zaleski J. On the quantitation of ammonia in animal fluids and tissues. Naunyn Schmiedebergs Arch Pharmacol 1895, 36:385-396.
40. Matthews S.A. Ammonia, a causative factor in meat poisoning in Eck fistula dogs. Am J Physiol 1922, 59:459-460.
41. Shawcross D., Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci 2005, 62(19-20):2295-2304.
42. Seyan A.S., Hughes R.D., Shawcross D.L. Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. World J Gastroenterol 2010, 16(27):3347-3357.
43. Charlton M. Branched-chain amino acid enriched supplements as therapy for liver disease. J Nutr 2006, 136(Suppl 1):295S-298S.
44. Fischer J.E., Baldessarini R.J. False neurotransmitters and hepatic failure. Lancet 1971, 2(7715):75-80.
45. Als-Nielsen B., Koretz R.L., Gluud L.L., et al. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev 2003, 2. CD001939.
46. Horst D., Grace N.D., Conn H.O., et al. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology 1984, 4(2):279-287.
47. Marchesini G., Bianchi G., Merli M., et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 2003, 124:1792-1801.
48. Muto Y., Sato S., Watanabe A., et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005, 3:705-713.
49. Sato S., Watanabe A., Muto Y., et al. Clinical comparison of branched-chain amino acid (l-leucine, l-isoleucine, l-valine) granules and oral nutrition for hepatic insufficiency with decompensated liver cirrhosis (LIV-EN Study). Hepatol Res 2005, 31(4):232-240.
50. Plauth M., Cabre E., Campillo B., et al. ESPEN guidelines on parenteral nutrition: hepatology. Clin Nutr 2009, 28:436-444.
51. Ziser A., Plevak D.J. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Curr Opin Anaesthesiol 2001, 14(6):707-711.
52. Doberneck R.C., Sterling W.A., Allison D.C. Morbidity and mortality after operation in nonbleeding cirrhotic patients. Am J Surg 1983, 146(3):306-309.
53. Rice H.E., O'Keefe G.E., Helton W.S., et al. Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. Arch Surg 1997, 132(8):880-884. [discussion: 884-5].
54. Garrison R.N., Cryer H.M., Howard D.A., et al. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984, 199(6):648-655.
55. Selberg O., Bottcher J., Tusch G., et al. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters. Hepatology 1997, 25:652-657.
56. Fan S.T., Lo C.M., Lai E.C., et al. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 1994, 331(23):1547-1552.
57. Stephenson G.R., Moretti E.W., El-Moalem H., et al. Malnutrition in liver transplant patients: preoperative subjective global assessment is predictive of outcome after liver transplantation. Transplantation 2001, 72(4):666-670.
58. Merli M., Giusto M., Gentili F., et al. Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int 2010, 30(2):208-214.
59. Figueiredo F., Dickson E.R., Pasha T., et al. Impact of nutritional status on outcomes after liver transplantation. Transplantation 2000, 70(9):1347-1352.
60. de Luis D.A., Izaola O., Velicia M.C., et al. Impact of dietary intake and nutritional status on outcomes after liver transplantation. Rev Esp Enferm Dig 2006, 98(1):6-13.
61. Shahid M., Johnson J., Nightingale P., et al. Nutritional markers in liver allograft recipients. Transplantation 2005, 79(3):359-362.